ABSTRACT
There is a growing appreciation that both giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely interrelated conditions that have significant overlap in aetiology, clinical characteristics and treatment regimens. Subclinical GCA in PMR is becoming increasingly recognised, and there is evolving evidence that this may be a more aggressive disease phenotype than PMR. Ultrasound (US) lends itself well as a screening tool for GCA in PMR; it is inexpensive, non-invasive, widely available, lacks ionising radiation, may be performed at the bedside and is recommended by EULAR as a first-line investigation for suspected GCA. There is insufficient evidence to currently recommend that all patients with PMR should have a US assessment for vascular involvement. However, as clinical and laboratory parameters alone do not accurately diagnose patients with subclinical GCA, we suggest that vascular US will be increasingly performed by rheumatologists in practice to identify these patients with PMR, preferably as part of larger prospective outcome studies.
Subject(s)
Giant Cell Arteritis , Polymyalgia Rheumatica , Ultrasonography , Humans , Giant Cell Arteritis/diagnostic imaging , Polymyalgia Rheumatica/diagnostic imaging , Temporal Arteries/diagnostic imaging , Temporal Arteries/pathology , Ultrasonography/methodsABSTRACT
OBJECTIVE: The aim of the present study was to determine the clinical significance of subclinical giant cell arteritis (GCA) in polymyalgia rheumatica (PMR) and ascertain its optimal treatment approach. METHODS: Patients with PMR who fulfilled the 2012 European Alliance of Associations for Rheumatology/American College of Rheumatology Provisional Classification Criteria for PMR, did not have GCA symptoms and were routinely followed up for 2 years and were stratified into two groups, according to their ultrasound results: isolated PMR and PMR with subclinical GCA. The outcomes (relapses, glucocorticoid use and disease-modifying antirheumatic drug treatments) between groups were compared. RESULTS: We included 150 patients with PMR (50 with subclinical GCA) with a median (IQR) follow-up of 22 (20-24) months. Overall, 47 patients (31.3 %) had a relapse, 31 (62%) in the subclinical GCA group and 16 (16%) in the isolated PMR group (p<0.001). Among patients with subclinical GCA, no differences were found in the mean (SD) prednisone starting dosage between relapsed and non-relapsed patients (32.4±15.6 vs 35.5±12.1 mg, respectively, p=0.722). Patients with subclinical GCA who relapsed had a faster prednisone dose tapering in the first 3 months compared with the non-relapsed patients, with a mean dose at the third month of 10.0±5.2 versus 15.2±7.9 mg daily (p<0.001). No differences were found between relapsing and non-relapsed patients with subclinical GCA regarding age, sex, C reactive protein and erythrocyte sedimentation rate. CONCLUSIONS: Patients with PMR and subclinical GCA had a significantly higher number of relapses during a 2-year follow-up than patients with isolated PMR. Lower starting doses and rapid glucocorticoid tapering in the first 3 months emerged as risk factors for relapse.
Subject(s)
Giant Cell Arteritis , Polymyalgia Rheumatica , Humans , Giant Cell Arteritis/diagnostic imaging , Giant Cell Arteritis/drug therapy , Giant Cell Arteritis/complications , Polymyalgia Rheumatica/complications , Prednisone/therapeutic use , Glucocorticoids/therapeutic use , RecurrenceABSTRACT
OBJECTIVES: The main objective was to generate a GLobal OMERACT Ultrasound DActylitis Score (GLOUDAS) in psoriatic arthritis and to test its reliability. To this end, we assessed the validity, feasibility and applicability of ultrasound assessment of finger entheses to incorporate them into the scoring system. METHODS: The study consisted of a stepwise process. First, in cadaveric specimens, we identified enthesis sites of the fingers by ultrasound and gross anatomy, and then verified presence of entheseal tissue in histological samples. We then selected the entheses to be incorporated into a dactylitis scoring system through a Delphi consensus process among international experts. Next, we established and defined the ultrasound components of dactylitis and their scoring systems using Delphi methodology. Finally, we tested the interobserver and intraobserver reliability of the consensus- based scoring systemin patients with psoriatic dactylitis. RESULTS: 32 entheses were identified in cadaveric fingers. The presence of entheseal tissues was confirmed in all cadaveric samples. Of these, following the consensus process, 12 entheses were selected for inclusion in GLOUDAS. Ultrasound components of GLOUDAS agreed on through the Delphi process were synovitis, tenosynovitis, enthesitis, subcutaneous tissue inflammation and periextensor tendon inflammation. The scoring system for each component was also agreed on. Interobserver reliability was fair to good (κ 0.39-0.71) and intraobserver reliability good to excellent (κ 0.80-0.88) for dactylitis components. Interobserver and intraobserver agreement for the total B-mode and Doppler mode scores (sum of the scores of the individual abnormalities) were excellent (interobserver intraclass correlation coefficient (ICC) 0.98 for B-mode and 0.99 for Doppler mode; intraobserver ICC 0.98 for both modes). CONCLUSIONS: We have produced a consensus-driven ultrasound dactylitis scoring system that has shown acceptable interobserver reliability and excellent intraobserver reliability. Through anatomical knowledge, small entheses of the fingers were identified and histologically validated.
Subject(s)
Arthritis, Psoriatic , Finger Joint , Severity of Illness Index , Ultrasonography , Humans , Arthritis, Psoriatic/diagnostic imaging , Reproducibility of Results , Finger Joint/diagnostic imaging , Finger Joint/pathology , Ultrasonography/methods , Male , Female , Delphi Technique , Synovitis/diagnostic imaging , Synovitis/pathology , Middle Aged , Observer Variation , Enthesopathy/diagnostic imaging , Tenosynovitis/diagnostic imaging , Cadaver , Feasibility Studies , Adult , Aged , Fingers/diagnostic imaging , Fingers/pathologyABSTRACT
OBJECTIVES: Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for people with rheumatic disease in Ireland. METHODS: Data entered into the C19-GRA provider registry from Ireland between 24 March 2020 and 9 July 2021 were analysed. Differences in the likelihood of hospitalization and mortality according to demographic and clinical variables were investigated using Chi-squared test or Fisher's exact test, as appropriate. Trends in odds of hospitalization and mortality over time were investigated using logistic regression with the time period as a categorical variable. RESULTS: Of 212 cases included, 59.4% were female and median age was 58.0 years (range 13-96). Of the 212 cases, 92 (43%) were hospitalized and 22 (10.4%) died. Increasing age, a diagnosis of gout, ever smoking, glucocorticoid use, having comorbidities and specific comorbidities of cancer, cardiovascular and pulmonary disease were more common in those hospitalized. A diagnosis of inflammatory arthritis, csDMARD and/or b/tsDMARD use were less frequent in those hospitalized. Increasing age, a diagnosis of gout, ever smoking, having comorbidities and specific comorbidities of obesity, cardiovascular and pulmonary disease were more common in those who died. Odds of hospitalization or mortality did not change over time. CONCLUSION: No temporal trend was observed in either COVID-19-related hospitalization or mortality outcomes for people with rheumatic disease in Ireland.
Subject(s)
COVID-19 , Gout , Rheumatic Diseases , Rheumatology , Adolescent , Adult , Aged , Aged, 80 and over , COVID-19/epidemiology , Female , Humans , Ireland/epidemiology , Male , Middle Aged , Registries , Rheumatic Diseases/epidemiology , SARS-CoV-2 , Young AdultABSTRACT
In the setting of the coronavirus disease 2019 (COVID-19) pandemic, an emergency hospital-wide eWork policy was enacted at Boston Children's Hospital on March 16, 2020. The number of clinicians on campus was restricted to only essential personnel, guidelines limited clinical care delivery to solely non-elective patients, and strict maximums were placed on the numbers of people allowed to congregate in the same physical space. With this abrupt transition to social distancing and electronic communication, the established approach to educating graduate medical trainees became obsolete overnight. Anticipating significant impact on trainee and faculty professional and personal lives, the importance of adaptive teaching strategies was evident. This document details one approach to redesigning the clinical learning system including a description of the learners and environment, the pedagogical principles that guided the approach, and technological tools used in implementation. Additionally, available literature pertinent to this topic is explored, assessment of the work to date is presented, and suggestions are provided regarding future directions related to online graduate medical education.
ABSTRACT
OBJECTIVE: As part of European League against Rheumatism (EULAR)/European Musculoskeletal Conditions Surveillance and Information Network, 20 user-focused standards of care (SoCs) for rheumatoid arthritis (RA) addressing 16 domains of care were developed. This study aimed to explore gaps in implementation of these SoCs across Europe. METHODS: Two cross-sectional surveys on the importance, level of and barriers (patients only) to implementation of each SoC (0-10, 10 highest) were designed to be conducted among patients and rheumatologists in 50 European countries. Care gaps were calculated as the difference between the actual and maximum possible score for implementation (ie, 10) multiplied by the care importance score, resulting in care gaps (0-100, maximal gap). Factors associated with the problematic care gaps (ie, gap≥30 and importance≥6 and implementation<6) and strong barriers (≥6) were further analysed in multilevel logistic regression models. RESULTS: Overall, 26 and 31 countries provided data from 1873 patients and 1131 rheumatologists, respectively. 19 out of 20 SoCs were problematic from the perspectives of more than 20% of patients, while this was true for only 10 SoCs for rheumatologists. Rheumatologists in countries with lower gross domestic product and non-European Union countries were more likely to report problematic gaps in 15 of 20 SoCs, while virtually no differences were observed among patients. Lack of relevance of some SoCs (71%) and limited time of professionals (66%) were the most frequent implementation barriers identified by patients. CONCLUSIONS: Many problematic gaps were reported across several essential aspects of RA care. More efforts need to be devoted to implementation of EULAR SoCs.
Subject(s)
Arthritis, Rheumatoid , Rheumatology/standards , Standard of Care , Adult , Aged , Cross-Sectional Studies , Europe , Female , Humans , Male , Middle Aged , Registries , Rheumatologists , Surveys and QuestionnairesABSTRACT
OBJECTIVES: To develop and test the reliability of a new semiquantitative scoring system for the assessment of cartilage changes by ultrasound in a web-based exercise as well as a patient exercise of patients with RA. METHODS: A taskforce of the Outcome Measures in Rheumatology Ultrasound Working Group performed a systematic literature review on the US assessment of cartilage in RA, followed by a Delphi survey on cartilage changes and a new semiquantitative US scoring system, and finally a web-based exercise as well as a patient exercise. For the web-based exercise, taskforce members scored a dataset of anonymized static images of MCP joints in RA patients and healthy controls, which also contained duplicate images. Subsequently, 12 taskforce members used the same US to score cartilage in MCP and proximal interphalangeal joints of six patients with RA in in a patient reliability exercise. Percentage agreement and prevalence of lesions were calculated, as intrareader reliability was assessed by weighted kappa and interreader reliability by Light's kappa. RESULTS: The three-grade semiquantitative scoring system demonstrated excellent intrareader reliability (kappa: 0.87 and 0.83) in the web-based exercise and the patient exercise, respectively. Interreader reliability was good in the web-based exercise (kappa: 0.64) and moderate (kappa: 0.48) in the patient exercise. CONCLUSION: Our study demonstrates that ultrasound is a reliable tool for evaluating cartilage changes in the MCP joints of patients with RA and supports further development of a new reliable semiquantitative ultrasound scoring system for evaluating cartilage involvement in RA.
Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Cartilage/diagnostic imaging , Rheumatology/methods , Severity of Illness Index , Ultrasonography/statistics & numerical data , Adult , Advisory Committees , Delphi Technique , Female , Humans , Male , Metacarpophalangeal Joint/diagnostic imaging , Middle Aged , Observer Variation , Reproducibility of Results , Ultrasonography/methodsABSTRACT
In 1986, Paul Whittle investigated the ability to discriminate between the luminance of two small patches viewed upon a uniform background. In 1992, Paul Whittle asked subjects to manipulate the luminance of a number of patches on a uniform background until their brightness appeared to vary from black to white with even steps. The data from the discrimination experiment almost perfectly predicted the gradient of the function obtained in the brightness experiment, indicating that the two experimental methodologies were probing the same underlying mechanism. Whittle introduced a model that was able to capture the pattern of discrimination thresholds and, in turn, the brightness data; however, there were a number of features in the data set that the model couldn't capture. In this paper, we demonstrate that the models of Kane and Bertalmío (2017) and Kingdom and Moulden (1991) may be adapted to predict all the data but only by incorporating an accurate model of detection thresholds. Additionally, we show that a divisive gain model may also capture the data but only by considering polarity-dependent, nonlinear inputs following the underlying pattern of detection thresholds. In summary, we conclude that these models provide a simple link between detection thresholds, discrimination thresholds, and brightness perception.
Subject(s)
Contrast Sensitivity/physiology , Discrimination, Psychological/physiology , Pattern Recognition, Visual/physiology , Sensory Thresholds/physiology , Adult , Humans , Lighting , Models, TheoreticalABSTRACT
The statistics of real world images have been extensively investigated, but in virtually all cases using only low dynamic range image databases. The few studies that have considered high dynamic range (HDR) images have performed statistical analyses categorizing images as HDR according to their creation technique, and not to the actual dynamic range of the underlying scene. In this study we demonstrate, using a recent HDR dataset of natural images, that the statistics of the image as received at the camera sensor change dramatically with dynamic range, with particularly strong correlations with dynamic range being observed for the median, standard deviation, skewness, and kurtosis, while the one over frequency relationship for the power spectrum breaks down for images with a very high dynamic range, in practice making HDR images not scale invariant. Effects are also noted in the derivative statistics, the single pixel histograms, and the Haar wavelet analysis. However, we also show that after some basic early transforms occurring within the eye (light scatter, nonlinear photoreceptor response, center-surround modulation) the statistics of the resulting images become virtually independent from the dynamic range, which would allow them to be processed more efficiently by the human visual system.
Subject(s)
Models, Statistical , Psychomotor Performance/physiology , Visual Perception/physiology , Contrast Sensitivity/physiology , Humans , Signal Processing, Computer-AssistedSubject(s)
Giant Cell Arteritis , Male , Humans , Giant Cell Arteritis/diagnosis , Prostate , Temporal ArteriesABSTRACT
OBJECTIVES: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis, with a strong heritable component, affecting patients with psoriasis. Here we attempt to identify genetic variants within the major histocompatibility complex (MHC) that differentiate patients with PsA from patients with cutaneous psoriasis alone (PsC). METHODS: 2808 patients with PsC, 1945 patients with PsA and 8920 population controls were genotyped. We imputed SNPs, amino acids and classical HLA alleles across the MHC and tested for association with PsA compared to population controls and the PsC patient group. In addition we investigated the impact of the age of disease onset on associations. RESULTS: HLA-C*06:02 was protective of PsA compared to PsC (p=9.57×10-66, OR 0.37). The HLA-C*06:02 risk allele was associated with a younger age of psoriasis onset in all patients (p=1.01×10-59). After controlling for the age of psoriasis onset no association of PsA to HLA-C*06:02 (p=0.07) was observed; instead, the most significant association was to amino acid at position 97 of HLA-B (p=1.54×10-9) where the presence of asparagine or serine residue increased PsA risk. Asparagine at position 97 of HLA-B defines the HLA-B*27 alleles. CONCLUSIONS: By controlling for the age of psoriasis onset, we show, for the first time, that HLA-C*06:02 is not associated with PsA and that amino acid position 97 of HLA-B differentiates PsA from PsC. This amino acid also represents the largest genetic effect for ankylosing spondylitis, thereby refining the genetic overlap of these two spondyloarthropathies. Correcting for bias has important implications for cross-phenotype genetic studies.
Subject(s)
Arthritis, Psoriatic/genetics , HLA-B27 Antigen/genetics , HLA-C Antigens/genetics , Major Histocompatibility Complex/genetics , Adolescent , Adult , Age of Onset , Alleles , Asparagine , Case-Control Studies , Genotype , Humans , Phenotype , Polymorphism, Single Nucleotide , Psoriasis/genetics , Serine , Young AdultABSTRACT
BACKGROUND: In 2001, the European League Against Rheumatism developed and disseminated the first guidelines for musculoskeletal (MS) ultrasound (US) in rheumatology. Fifteen years later, the dramatic expansion of new data on MSUS in the literature coupled with technological developments in US imaging has necessitated an update of these guidelines. OBJECTIVES: To update the existing MSUS guidelines in rheumatology as well as to extend their scope to other anatomic structures relevant for rheumatology. METHODS: The project consisted of the following steps: (1) a systematic literature review of MSUS evaluable structures; (2) a Delphi survey among rheumatologist and radiologist experts in MSUS to select MS and non-MS anatomic structures evaluable by US that are relevant to rheumatology, to select abnormalities evaluable by US and to prioritise these pathologies for rheumatology and (3) a nominal group technique to achieve consensus on the US scanning procedures and to produce an electronic illustrated manual (ie, App of these procedures). RESULTS: Structures from nine MS and non-MS areas (ie, shoulder, elbow, wrist and hand, hip, knee, ankle and foot, peripheral nerves, salivary glands and vessels) were selected for MSUS in rheumatic and musculoskeletal diseases (RMD) and their detailed scanning procedures (ie, patient position, probe placement, scanning method and bony/other landmarks) were used to produce the App. In addition, US evaluable abnormalities present in RMD for each anatomic structure and their relevance for rheumatology were agreed on by the MSUS experts. CONCLUSIONS: This task force has produced a consensus-based comprehensive and practical framework on standardised procedures for MSUS imaging in rheumatology.
Subject(s)
Musculoskeletal Diseases/diagnostic imaging , Rheumatic Diseases/diagnostic imaging , Rheumatology/standards , Ultrasonography/methods , Ultrasonography/standards , Consensus , Delphi Technique , Europe , HumansSubject(s)
Osteitis , Psoriasis/diagnosis , Sarcoidosis , Skin Diseases , Toe Phalanges , Wounds and Injuries/complications , Adolescent , Diagnosis, Differential , Disease Progression , Hallux/diagnostic imaging , Hallux/pathology , Humans , Male , Osteitis/complications , Osteitis/physiopathology , Osteitis/therapy , Preventive Medicine , Prognosis , Sarcoidosis/diagnosis , Sarcoidosis/immunology , Sarcoidosis/physiopathology , Sarcoidosis/therapy , Skin Diseases/diagnosis , Skin Diseases/etiology , Toe Phalanges/diagnostic imaging , Toe Phalanges/pathologyABSTRACT
System gamma is the end-to-end exponent that describes the relationship between the relative luminance values at capture and the reproduced image. The system gamma preferred by subjects is known to vary with the background luminance condition and the image in question. We confirm the previous two findings using an image database with both high and low dynamic range images (from 102 to 107), but also find that the preferred system gamma varies with the dynamic range of the monitor (CRT, LCD, or OLED). We find that the preferred system gamma can be predicted in all conditions and for all images by a simple model that searches for the value that best flattens the lightness distribution, where lightness is modeled as a power law of onscreen luminance. To account for the data, the exponent must vary with the viewing conditions. The method presented allows the inference of lightness perception in natural scenes without direct measurement and makes testable predictions for how lightness perception varies with the viewing condition and the distribution of luminance values in a scene. The data from this paper has been made available online.
Subject(s)
Computer Terminals , Contrast Sensitivity/physiology , Light , Visual Perception/physiology , Humans , Models, TheoreticalABSTRACT
Sacroiliac (SI) region pain is a common clinical presentation and is often due to pathology involving the SI joints, usually of inflammatory, infective, neoplastic, or post-traumatic etiology. The SI joints have a unique anatomic layout and composition and can be imaged with a variety of techniques including conventional radiographs, computed tomography, isotope bone scintigraphy, and magnetic resonance imaging. This article reviews a range of common SI joint conditions, illustrated by multimodality imaging findings. We also discuss strategies for choosing the optimal imaging modality, pearls, and pitfalls of imaging and discuss an algorithm for approaching the patient with suspected inflammatory back pain.
Subject(s)
Sacroiliac Joint , Aged , Algorithms , Humans , Inflammation/diagnosis , Joint Diseases/diagnosis , Magnetic Resonance Imaging , Male , Pain , Spondylarthropathies/diagnosis , Spondylitis, Ankylosing/diagnosis , Tomography, X-Ray ComputedABSTRACT
To encode binocular disparity, the visual system determines the image patches in one eye that yield the highest correlation with patches in the other eye. The computation of interocular correlation occurs after spatiotemporal filtering of monocular signals, which leads to restrictions on disparity variations that can support depth perception. We quantified those restrictions by measuring humans' ability to see disparity variation at a wide range of spatial and temporal frequencies. Lower-disparity thresholds cut off at very low spatiotemporal frequencies, which is consistent with the behavior of V1 neurons. Those thresholds are space-time separable, suggesting that the underlying neural mechanisms are separable. We also found that upper-disparity limits were characterized by a spatiotemporal, disparity-gradient limit; to be visible, disparity variation cannot exceed a fixed amount for a given interval in space-time. Our results illustrate that the disparity variations that humans can see are very restricted compared with the corresponding luminance variations. The results also provide insight into the neural mechanisms underlying depth from disparity, such as why stimuli with long interocular delays can still yield clear depth percepts.
Subject(s)
Depth Perception/physiology , Visual Cortex/physiology , Adult , Female , Humans , Male , Time Factors , Young AdultABSTRACT
OBJECTIVES: Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis; it has a higher estimated genetic component than psoriasis alone, however most genetic susceptibility loci identified for PsA to date are also shared with psoriasis. Here we attempt to validate novel single nucleotide polymorphisms selected from our recent PsA Immunochip study and determine specificity to PsA. METHODS: A total of 15 single nucleotide polymorphisms were selected (PImmunochip <1×10(-4)) for validation genotyping in 1177 cases and 2155 controls using TaqMan. Meta-analysis of Immunochip and validation data sets consisted of 3139 PsA cases and 11 078 controls. Novel PsA susceptibility loci were compared with data from two large psoriasis studies (WTCCC2 and Immunochip) to determine PsA specificity. RESULTS: We found genome-wide significant association to rs2476601, mapping to PTPN22 (p=1.49×10(-9), OR=1.32), but no evidence for association in the psoriasis cohort (p=0.34) and the effect estimates were significantly different between PsA and psoriasis (p=3.2×10(-4)). Additionally, we found genome-wide significant association to the previously reported psoriasis risk loci; NOS2 (rs4795067, p=5.27×10(-9)). CONCLUSIONS: For the first time, we report genome-wide significant association of PTPN22 (rs2476601) to PsA susceptibility, but no evidence for association to psoriasis.
Subject(s)
Arthritis, Psoriatic/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics , Case-Control Studies , Female , Genetic Loci , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Humans , Male , Polymorphism, Single Nucleotide , Psoriasis/genetics , Risk FactorsABSTRACT
OBJECTIVE: US is a promising tool in evaluating RA synovitis, but abnormal US findings have been reported in small subsets of normal joints in healthy subjects. This study aimed to systematically assess greyscale US (GSUS) and power Doppler US (PDUS) findings in 40 peripheral joints-the 28-joint DAS (DAS28) set, ankles and MTP joints-in healthy subjects. A composite score of abnormal US findings in 40 joints was compared with serum levels of pro-inflammatory cytokines. METHODS: US of 60 standard views in 40 joints was performed in 30 healthy subjects (total 3600 images). GSUS and PDUS were scored semi-quantitatively (0-3). Serum samples were obtained at the time of US and analysed for IL-1α, IL-1ß, IL-2, IL-6, IL-8, VEGF, TNF-α and IFN-γ using biochip array technology. RESULTS: GSUS abnormalities were more frequent than PDUS abnormalities [mean total GSUS score = 20.07 (range 6-45; maximum potential score = 180), mean total PDUS score = 4.8 (range 0-13)]. GSUS score increased with increasing age (Spearman's ρ = 0.383, P = 0.037). A PDUS signal >1 was observed only in the wrist (8%) and MTP1 (3%). GSUS scores did not correlate with any pro-inflammatory cytokine level. The total PDUS score correlated significantly with serum VEGF (r = 0.395, P = 0.046). CONCLUSION: PDUS signals >1 are rarely seen in normal synovial joints. GSUS synovitis, but not PDUS, may reflect age-related joint changes. PDUS correlated with VEGF, providing further evidence of a central role for VEGF in synovial neo-angiogenesis.